H. Lee Moffitt Cancer Center and Research Institute [clinicaltrials_resource:dc8d7d016bfb687044db10537a8f9310]
Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer [clinicaltrials:NCT00002667]clinicaltrials:NCT00002670clinicaltrials:NCT00005612clinicaltrials:NCT00005624clinicaltrials:NCT00005626Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer [clinicaltrials:NCT00005640]Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer [clinicaltrials:NCT00006033]Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00006035]Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors [clinicaltrials:NCT00006088]clinicaltrials:NCT00012350BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00028561]Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 [clinicaltrials:NCT00031564]Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer [clinicaltrials:NCT00046540]Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer [clinicaltrials:NCT00080418]Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma [clinicaltrials:NCT00243035]Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors [clinicaltrials:NCT00331955]Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia [clinicaltrials:NCT00352677]clinicaltrials:NCT00387647A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes [clinicaltrials:NCT00458159]clinicaltrials:NCT00470301Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00553332]1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery [clinicaltrials:NCT00567931]clinicaltrials:NCT00604721clinicaltrials:NCT00606008clinicaltrials:NCT00609765clinicaltrials:NCT00612677clinicaltrials:NCT00617591clinicaltrials:NCT00617617clinicaltrials:NCT00624585clinicaltrials:NCT00665002clinicaltrials:NCT00673738clinicaltrials:NCT00720096clinicaltrials:NCT00747643clinicaltrials:NCT00750815clinicaltrials:NCT00751140A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies [clinicaltrials:NCT00830869]clinicaltrials:NCT00831766clinicaltrials:NCT00835679clinicaltrials:NCT00910858
location [clinicaltrials_vocabulary:location]
H. Lee Moffitt Cancer Center and Research Institute [clinicaltrials_resource:dc8d7d016bfb687044db10537a8f9310]
Bio2RDF identifier
dc8d7d016bfb687044db10537a8f9310
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:dc8d7d016bfb687044db10537a8f9310
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:dc8d7d016bfb687044db10537a8f9310
title
H. Lee Moffitt Cancer Center and Research Institute
@en
type
label
H. Lee Moffitt Cancer Center a ...... d7d016bfb687044db10537a8f9310]
@en